Erika Smith of ReNetX fights spinal cord injuries
Two years ago, Erika R. Smith left her job as director of the Blavatnik Fund for Innovation at Yale to become chief executive officer of...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Two years ago, Erika R. Smith left her job as director of the Blavatnik Fund for Innovation at Yale to become chief executive officer of...
An experimental ALS drug being developed in New Haven will be tested next year in a first-of-its-kind clinical trial led by Massachusetts General Hospital. Biohaven Pharmaceuticals’...
Bayer and Arvinas have launched a new company, Oerth Bio, to leverage Arvinas’ expertise in targeted protein degradation and Bayer’s experience in developing human therapies and...
Achillion Pharmaceuticals reports that the FDA has granted Breakthrough Therapy designation for danicopan (ACH-4471) for treatment in combination with a C5 monoclonal antibody for patients...
BioCT invites your nominations for the 2019 Entrepreneur of the Year Award. The Entrepreneur of the Year Award was established by BioCT and Shipman and...
SpringWorks reports that the European Commission has granted Orphan Drug Designation for nirogacestat, an oral, selective, small molecule, gamma-secretase inhibitor, for the treatment of soft...
Researchers at The Jackson Laboratory are using genomic technologies and specialized mouse models to decipher the changes that occur as a consequence of aging in...
As a result of a recent large-scale global survey, tapeworms, a class which encompasses more than 5,000 species, are now one of the most well-known...
Thirty years ago, the idea of starting a biotech venture in Connecticut was rare, if not unheard of. The obvious biotech hotbeds in the United...
BioXcel Therapeutics has announced a strategic plan to investigate the development of using wearable digital device technology, such as the Apple Watch, with the goal of...